Computational Phenotype of Acute and Long-term Kidney Disease in Children with Septic Shock
This study aims to expand understanding of how crystalloid fluid impacts sepsis survivors’ lives beyond 30 days. Aim 1: Determine the most effective crystalloid fluid choice to minimize sepsis-induced AKI and CKD in PRoMPT BOLUS trial participants Aim 2: Measure the real-world impact of crystalloid fluid on sepsis-induced AKI and CKD